News2022-02-18T12:03:25+00:00

News & Events

News & Events

News
& Events

Upcoming Events

News

All News & Events

Biosphere tenant Iksuda Therapeutics presents first data on lead antibody drug conjugate, demonstrating effective tumour regression.

By |September 30th, 2019|Categories: Archive|

Iksuda Therapeutics (Iksuda), a developer of next generation Antibody

Comments Off on Biosphere tenant Iksuda Therapeutics presents first data on lead antibody drug conjugate, demonstrating effective tumour regression.

Case studies

Go to Top